Skip to Main Content Menu Search Site

HarborSite: Precise and Efficient Gene Editing for Next-Generation Gene Therapies

Integration of therapeutic genes into genomic safe harbors using highly specific and efficient recombinases could enable more predictable, safe, and durable gene therapies

Interested in helping de-risk and commercialize our technology?

The HarborSite team is currently expanding and looking for motivated Postdoctoral Fellows and interns to join their project.


Synthetic Biology

Technology Development Team
Key Features
  • Integration of genes into genomic safe harbor (GSH) sites ensures their safe and prolonged expression
  • Recombinase enzymes (recombinases) enable precise and efficient genome integration of large therapeutic gene sequences
  • HarborSite platform enables safe and durable gene and cell therapies for diseases of liver, blood, lung, skin, and other tissues
Close menu